Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Coumadin warfarin regulatory update

FDA approved a label change for warfarin to include an explanation that genetic makeup may influence

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE